PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, today announced it has closed a $50 million debt facility from Silicon Valley Bank (SVB) to further support its working capital growth, along with adding dry powder for future acquisitions. The agreement allows the company to retire its […]

On May 9, 2019, MGI disclosed that its first round of fundraising exceeded US$200 million, the largest amount of capital raised in the genetic field in China in 2018. Investors included well-known institutions such as CITIC, Jinshi Capital, Songhe Capital and Dongzheng Capital. MGI Highlights Rapid Progress in Transforming Industry In recent years, the gene […]

Genome Diagnostics B.V. (“GenDx”) announced today that Ampersand Capital Partners has completed a minority, growth equity investment in the company. Wietse Mulder, PhD., remains the majority shareholder and CEO of GenDx. The partnership between Ampersand and GenDx aims to foster sustainable growth, both organically and through M&A activities in the molecular diagnostic products and services […]

FUNDS WILL ENABLE DEVELOPMENT OF INSTRUMENT TO RAPIDLY AND DIRECTLY ANALYZE DRINKING WATER SAMPLES AT THE POINT OF COLLECTION.   FAYETTEVILLE, AR – Zebra Analytix™, a VIC Technology Venture Development portfolio company, announced today that it has received a National Institute of Environment Health Sciences (NIEHS) Small Business Innovation Research (SBIR) grant in the amount of $225,000. […]

Cambridge, United Kingdom – Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in additional equity investment, led by Parkwalk Advisors. The round attracted new strategic investors, including Digital China Health Technologies Corporation Limited (DCHealth), alongside follow-on funding from existing investors. The total amount raised across its B […]

908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced it has closed $17.5 million in a growth equity funding round.  This Series E funding brings the company’s total to $70M, making 908 Devices the most well-resourced upstart in the multibillion-dollar mass spectrometry market. The round was led by Northpond Ventures, […]

STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today that it has received the first $1 million of a $5 million licensing fee as per the terms of its exclusive agreement entered into with TheraCann International Corporation (“TheraCann”) on March […]

Locally-based company CSols, which provides laboratory informatics software services, has part-funded research being undertaken by one of the University of Liverpool’s Management School’s doctoral researchers. CSols software enables laboratories to improve efficiency by reducing costs, test turnaround times and transcription errors. The research is examining different models for monitoring and managing the carbon footprint of clinical laboratories, where […]

RESEARCH TRIANGLE PARK, N.C.–Cell Microsystems, a provider of innovative tools for single cell research, announced today it has received two NIH Small Business Innovation and Research awards totaling $1.9M to automate CRISPR workflows using its proprietary CellRaft Technology. Nick Trotta, PhD, Director of Genomics Programs, described the awards saying, “These grants will accelerate our on-going […]

Illumina Accelerator graduate companies have raised $190 million so far from leading life science and tech investors Illumina Accelerator turns five this year and is welcoming its ninth class of genomics startups to the growing network of successful companies. Since launching in 2014, Illumina Accelerator, the first business accelerator focused on creating an innovative ecosystem for early-stage genomics […]